Drug Shortages: How to weather the storm
Drug shortages are complex and multifaceted. Understanding the cause of shortages, what’s being done to address them by regulatory and industry stakeholders helps health care institutions address shortages. Understanding how to identify shortages, how to assess their severity, and how to mitigate their impact will ensure patient care is not affected by shortages. Through this CE, we will provide attendees the resources and tools to streamline the management of drug shortages.
- Recognize of the cause and effects of drug shortages
- Review regulatory calls to action and forward-thinking initiatives
- Present the concept of drug shortage stewardship
- Describe practices to manage drug shortages
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Absence of Relevant Financial Relationships
The following planners, faculty, and others in control of educational content have no relevant financial relationships with ineligible companies.
Brook DesRivieres, PharmD, MS, FACHE
Kyle Hoelting, PharmD, BCPS
Sr. Clinical Manager of Drug Information
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-22-013-L04-P and JA0006103-0000-22-013-L04-T
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician